Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine α3β2 receptors

Tse Yu Wu, Caleb M. Smith, Steven M. Sine, Mark M. Levandoski

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


We studied allosteric potentiation of rat α3β2 neuronal nicotinic acetylcholine receptors (nAChRs) by the anthelmintic compound morantel. Macroscopic currents evoked by acetylcholine (ACh) from nAChRs expressed in Xenopus laevis oocytes increase up to 8-fold in the presence of low concentrations of morantel (≤10 μM); the magnitude of the potentiation depends on both agonist and modulator concentrations. It is noteworthy that the potentiated currents exceed the maximum currents achieved by saturating (millimolar) concentrations of agonist. Studies of macroscopic currents elicited by prolonged drug applications (100-300 s) indicate that morantel does not increase α3β2 receptor activity by reducing slow (≥1 s) desensitization. Instead, using outside-out patch-clamp recordings, we demonstrate that morantel increases the frequency of single-channel openings and alters the bursting characteristics of the openings in a manner consistent with enhanced channel gating; these results quantitatively explain the macroscopic current potentiation. Morantel is a very weak agonist alone, but we show that the classic competitive antagonist dihydro-β-erythroidine inhibits morantel-evoked currents noncompetitively, indicating that morantel does not bind to the canonical ACh binding sites.

Original languageEnglish (US)
Pages (from-to)466-475
Number of pages10
JournalMolecular pharmacology
Issue number2
StatePublished - Aug 2008

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine α3β2 receptors'. Together they form a unique fingerprint.

Cite this